ESMO 2017 | What impact will biosimilars have on clinical life?

Biosimilars show significant promise in the treatment of cancer. Diana Lüftner, from the Humboldt University, Berlin, Germany talks to us about the impact that these agents will have on clinical life, and explains the process by which clinicians will assess and proceed with their use. This interview was recorded at the 2017 European Society for Medical Oncology (ESMO) held in Madrid, Spain.